TransMedics Group Appoints New CFO Fernando Araujo

What Happened
TransMedics Group, Inc. (TMDX) filed an 8-K on Sept 10, 2026 announcing that the Board has appointed Fernando Araujo as Chief Financial Officer and Treasurer effective Sept 21, 2026. Mr. Araujo, age 46, joins from GE HealthCare’s Advanced Imaging Solutions and previously held senior finance roles at 3M and GE. He succeeds Gerardo Hernandez (CFO since 2024), who will remain a non-executive employee through Dec 31, 2026 and serve as a non-employee senior advisor through Apr 30, 2027; Hernandez will receive severance under his existing retention agreement and will continue vesting of outstanding equity awards during the transition period.

Key Details

• Compensation: Araujo’s base salary is $590,000 with an annual bonus target of 60% of base (prorated for 2026). He receives a $200,000 cash sign‑on bonus (two installments) and equity grants with grant‑date values of ~ $1.75M (stock options) and ~ $1.75M (RSUs).
• Vesting & restrictive covenants: Option vests 25% after one year then monthly over three years; RSUs vest 25% on each of the first four anniversaries. He agreed to perpetual confidentiality, assignment of IP, and a 1‑year post‑termination non‑compete/non‑solicit.
• Severance: For a qualifying termination after 12 months, severance equals one year’s base salary plus the highest annual bonus in the prior three years (paid over 12 months), prorated bonus for the year of termination, and up to 12 months of health coverage. Shorter‑term terminations and change‑in‑control situations have specified alternative benefit levels (including a 1.5x base pay multiplier for certain CIC scenarios).
• Transition: Hernandez’s base salary stays $535,000 while non‑executive; he remains eligible for a 2026 bonus based on performance objectives and will not receive extra pay for advisory services beyond continued equity vesting.

Why It Matters
A CFO change is a material leadership shift that can affect investor views on financial strategy, reporting and operational priorities. The filing provides clear details on the new CFO’s compensation and potential costs to the company (cash sign‑on, ongoing salary, severance exposure and sizeable equity grants), all of which can affect near‑term cash flow and long‑term share dilution. The announced transition plan aims to preserve continuity—Hernandez stays on through year‑end and as an advisor—while giving investors explicit timelines and contractual protections (confidentiality, non‑compete) tied to the change. The company also issued a press release on Sept 10, 2026 (Exhibit 99.1).